1-8 of 8
Elke Jager
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB370: Tumor-infiltrating lymphocytes-derived CD8 clonotypes infiltrate the tumor tissue and mediate tumor regression in glioblastoma

Free
Lucas C M Arruda, Julia Karbach, Dragan Kiselicki, Hans-Michael Altmannsberger, Evgueni Sinelnikov, Dirk Gustavus, Hans Hoffmeister, Akin Atmaca, Elke Jäger
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_2): LB370.
https://doi.org/10.1158/1538-7445.AM2025-LB370
Published: 25 April 2025
View article titled, Abstract LB370: Tumor-infiltrating lymphocytes-derived CD8 clonotypes infiltrate the tumor tissue and mediate tumor regression in glioblastoma
Journal Articles

Abstract CT217: An open-label, Phase I/IIa study of VB10.NEO (DIRECT-01) in combination with checkpoint blockade in patients with locally advanced or metastatic solid tumors including melanoma, NSCLC, renal cell carcinoma, urothelial cancer or SSCHN

Free
Jurgen Krauss, Angela Krackhardt, Elke Jager, Anja Williams, Hedda Wold, Lisa Gerner, Monika Sekelja, Karoline Schjetne, Agnete B. Fredriksen, Mads Axelsen
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT217.
https://doi.org/10.1158/1538-7445.AM2019-CT217
Published: 01 July 2019
View article titled, Abstract CT217: An open-label, Phase I/IIa study of VB10.NEO (DIRECT-01) in combination with checkpoint blockade in patients with locally advanced or metastatic solid tumors including melanoma, NSCLC, renal cell carcinoma, urothelial cancer or SSCHN
Journal Articles

Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies

Free
Julia Karbach, Antje Neumann, Claudia Wahle, Kathrin Brand, Sacha Gnjatic, Elke Jäger
Journal: Cancer Research
Cancer Res (2012) 72 (17): 4304–4310.
https://doi.org/10.1158/0008-5472.CAN-12-0257
Published: 30 August 2012
View article titled, Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies
Open the PDF for Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies in another window
Includes: Supplementary data
Journal Articles

Abstract #735: Natural and in vitro primed T cell reactivity against p16INK4a support future active immunization of cervical cancer patients with this antigen

Free
Miriam Reuschenbach, Julia Karbach, Denise Eschenbach, Jonas Stanke, Justine Dokoupil, Kristina Nehls, Nicolas Wentzensen, Andreas Kaufmann, Elke Jäger, Magnus von Knebel Doeberitz
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 735.
Published: 01 May 2009
View article titled, Abstract #735: Natural and in vitro primed T cell reactivity against p16INK4a support future active immunization of cervical cancer patients with this antigen
Journal Articles

Induction of anti-tumor immune responses by DNA vaccines encoding tumor antigens targeted to professional antigen presenting cells

Free
Arjen Sloots, Cristina Mastini, Florian Rohrbach, Claudia Curcio, Robert Weth, Elke Jager, Guido Forni, Federica Cavallo, Winfried Wels
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1886.
Published: 01 May 2007
View article titled, Induction of anti-tumor immune responses by DNA vaccines encoding tumor antigens targeted to professional antigen presenting cells
Journal Articles

Molecular Cloning of hMena (ENAH) and Its Splice Variant hMena+11a: Epidermal Growth Factor Increases Their Expression and Stimulates hMena+11a Phosphorylation in Breast Cancer Cell Lines

Free
Francesca Di Modugno, Lucia DeMonte, Michele Balsamo, Giovanna Bronzi, Maria Rita Nicotra, Massimo Alessio, Elke Jager, John S. Condeelis, Angela Santoni, Pier Giorgio Natali, Paola Nisticò
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2657–2665.
https://doi.org/10.1158/0008-5472.CAN-06-1997
Published: 15 March 2007
View article titled, Molecular Cloning of hMena (ENAH) and Its Splice Variant hMena+11a: Epidermal Growth Factor Increases Their Expression and Stimulates hMena+11a Phosphorylation in Breast Cancer Cell Lines
Open the PDF for Molecular Cloning of hMena (ENAH) and Its Splice Variant hMena+11a: Epidermal Growth Factor Increases Their Expression and Stimulates hMena+11a Phosphorylation in Breast Cancer Cell Lines in another window
Journal Articles

The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and in HER2 positive/hormonal receptor negative tumors

Free
Marcella Mottolese, Francesca Di Modugno, Anna Di Benedetto, Flavia Novelli, Andrea Conidi, Letizia Perracchio, Irene Venturo, Ilaria Targa, Elke Jager, Angela Santoni, Pier Giorgio Natali, Paola Nisticò
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 842.
Published: 15 April 2006
View article titled, The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and in HER2 positive/hormonal receptor negative tumors
Journal Articles

Endothelial P-Selectin as a Target of Heparin Action in Experimental Melanoma Lung Metastasis

Free
Ralf J. Ludwig, Beatrice Boehme, Maurizio Podda, Reinhard Henschler, Elke Jager, Christa Tandi, Wolf-Henning Boehncke, Thomas M. Zollner, Roland Kaufmann, Jens Gille
Journal: Cancer Research
Cancer Res (2004) 64 (8): 2743–2750.
https://doi.org/10.1158/0008-5472.CAN-03-1054
Published: 15 April 2004
View article titled, Endothelial P-Selectin as a Target of Heparin Action in Experimental Melanoma Lung Metastasis
Open the PDF for Endothelial P-Selectin as a Target of Heparin Action in Experimental Melanoma Lung Metastasis in another window